Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-064135
Filing Date
2012-11-20
Accepted
2012-11-20 13:35:49
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v326815_10q.htm 10-Q 280470
2 EX-31.1 v326815_ex31-1.htm EX-31.1 8098
3 EX-31.2 v326815_ex31-2.htm EX-31.2 8429
4 EX-32.1 v326815_ex32-1.htm EX-32.1 4550
5 EX-32.2 v326815_ex32-2.htm EX-32.2 4515
  Complete submission text file 0001144204-12-064135.txt   3290989

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ilnc-20120930.xml EX-101.INS 309474
7 XBRL TAXONOMY EXTENSION SCHEMA ilnc-20120930.xsd EX-101.SCH 45333
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ilnc-20120930_cal.xml EX-101.CAL 25738
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ilnc-20120930_def.xml EX-101.DEF 173333
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ilnc-20120930_lab.xml EX-101.LAB 304306
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ilnc-20120930_pre.xml EX-101.PRE 211414
Mailing Address 45 WEST 36TH STREET 3RD FLOOR NEW YORK NY 10018
Business Address 45 WEST 36TH STREET 3RD FLOOR NEW YORK NY 10018 201 608-5102
Intellect Neurosciences, Inc. (Filer) CIK: 0001337905 (see all company filings)

EIN.: 208329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-128226 | Film No.: 121217398
SIC: 2834 Pharmaceutical Preparations